BD Covid Test Has Increased Risk of False Positives: FDA

July 29, 2021, 7:34 PM

The FDA said it’s alerting clinical laboratory staff and health care providers of an increased risk of false positives with BD SARS-CoV-2 Reagents for the BD Max System test.

  • In one study, the manufacturer found about 3% of results were false positives, according to a statement on the agency’s website
  • The FDA recommends that any positive result using the BD SARS-CoV-2 Reagents for the BD Max System should be considered presumptive

To contact the reporter on this story:
Greg Chang in San Francisco at gchang1@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2021 Bloomberg ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.